Immediate Impact

12 standout
Sub-graph 1 of 6

Citing Papers

T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2025 Standout
Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients
2024 Standout
1 intermediate paper

Works of Raphael Teipel being referenced

Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment
2022

Author Peers

Author Last Decade Papers Cites
Raphael Teipel 131 70 38 55 21 185
Natalie Schub 163 138 28 56 20 284
Zoé Van de Wyngaert 132 62 24 78 22 181
Olga Grishina 157 45 58 51 16 262
A Montuoro 149 71 59 41 20 213
Rossana Putzulu 128 50 42 152 26 284
Diego V. Clé 74 25 48 52 21 177
Laura Anna Pezzetti 82 51 19 48 18 163
Eva Wagner-Drouet 83 72 10 50 25 160
Massimo Fabrizio Martelli 136 63 68 40 25 257
James H. Jerkins 157 69 30 33 24 215

All Works

Loading papers...

Rankless by CCL
2026